Sökning: L773:1048 891X OR L773:1525 1438 >
First-line treatmen...
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.
-
- Kristensen, G B (författare)
- Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
-
- Vergote, I (författare)
- Department of Gynecologic Oncology, U.Z. Gasthuisberg, Leuven, Belgium
-
- Stuart, G (författare)
- Department of Gynecologic Oncology, Tom Baker Cancer Center, Calgary, Canada
-
visa fler...
-
- Del Campo, J M (författare)
- Department of Medical Oncology, Hospital General Vall d'Hebron, Barcelona, Spain
-
- Kaern, J (författare)
- Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
-
- Lopez, A B (författare)
- Department of Gynaecological Oncology, Gateshead Hospital, Gateshead, United Kingdom
-
- Eisenhauer, E (författare)
- NCI Canada Clinical Trials Group, Kingston, Canada
-
- Åvall-Lundquist, Elisabeth (författare)
- Department of Gynecologic Oncology, Karolinska Hospital, Stockholm, Sweden
-
- Ridderheim, Mona (författare)
- Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Havsteen, H (författare)
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
-
- Mirza, M R (författare)
- Department of Oncology, Odense University Hospital, Odense, Denmark
-
- Scheistroen, M (författare)
- Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
-
- Vrdoljak, E (författare)
- Department of Oncology, University Hospital, Split, Croatia
-
visa färre...
-
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway Department of Gynecologic Oncology, UZ. Gasthuisberg, Leuven, Belgium (creator_code:org_t)
- Lippincott Williams & Wilkins, 2003
- 2003
- Engelska.
-
Ingår i: International Journal of Gynecological Cancer. - : Lippincott Williams & Wilkins. - 1048-891X .- 1525-1438. ; 13:s2, s. 172-177
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://lup.lub.lu.s...
-
visa färre...
Abstract
Ämnesord
Stäng
- The objective of this study was to compare the safety and efficacy of carboplatin plus epirubicin and paclitaxel (TEC) to carboplatin and paclitaxel (TC), in the treatment of epithelial ovarian, peritoneal, or tubal carcinoma. Between March 1999 and August 2001, 887 patients were randomized to receive six to nine cycles of paclitaxel (175 mg/m2, 3 h intravenously) followed by carboplatin (AUC 5, Calvert formula) with or without epirubicin (75 mg/m2 intravenously prior to paclitaxel), on a 3-weekly schedule. The primary endpoint was progression-free survival. Demographic information: Residual disease <1 cm was reported on 41% of patients. At the end of treatment, 65% in the TEC and 55% in the TC arm had achieved a clinical complete response, and 18 and 25% a clinical partial response resulting in an overall response rate of 83% in the TEC and 80% in the TC arm, whereas 7 and 9% had progressive disease, respectively. The three-drug combination produced a markedly higher myelotoxicity, resulting in a higher frequency of febrile neutropenia (12.5% of the TEC and 1.5% of the TC patients) and a higher number of dose reductions and treatment delays. Cycle prolongation above seven days was seen in 7 and 5% of cycles in the TEC and TC arm, respectively. Stomatitis > or = grade 3 was also higher with TEC (4% TEC and 0.5% TC). Reductions in left ventricular ejection fraction of more than 15% after six courses were slightly more common with the TEC regimen (3% versus 1.5%), but the difference was not statistically significant (P = 0.2). In conclusion, treatment with the TEC combination produced a higher rate of complete responses than treatment with the TC combination. Toxicity was manageable. Long-term survival data are awaited.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- anthracycline
- chemotherapy
- ovarian carcinoma
- ovarian carcinoma
- anthracycline
- chemotherapy
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kristensen, G B
-
Vergote, I
-
Stuart, G
-
Del Campo, J M
-
Kaern, J
-
Lopez, A B
-
visa fler...
-
Eisenhauer, E
-
Åvall-Lundquist, ...
-
Ridderheim, Mona
-
Havsteen, H
-
Mirza, M R
-
Scheistroen, M
-
Vrdoljak, E
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
International Jo ...
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet
-
Lunds universitet